Key result
The abstract describes a study sequencing TTN in patients with end-stage dilated cardiomyopathy following LVAD support, but reports no quantitative results.
Why the study?
Does the presence of TTN-truncating variants affect the likelihood of cardiac function recovery in patients with end-stage DCM following LVAD support?
Observational
Does the presence of TTN-truncating variants affect the likelihood of cardiac function recovery in patients with end-stage DCM following LVAD support?
This study investigates whether genetic factors, specifically TTN-truncating variants, influence the potential for cardiac recovery in end-stage dilated cardiomyopathy patients on LVAD support.
May support expectant management in TTNtv DCM; hypothesis-generating for genotype-stratified prognosis and trials.
Recovery of Cardiac Function in Cardiomyopathy Caused by Titin TruncationDilated cardiomyopathy (DCM) is a frequent cause of heart failure and a common indication for heart transplantation.Dilated cardiomyopathy has a strong genetic basis, and the most common disease-causing mutations are variants that truncate the sarcomeric protein titin (TTN-truncating variants [TTNtvs] are prevalent in 25% 1 of familial DCM cases and 13% 2 of idiopathic DCM cases).The prognosis of DCM is poor, but functional recovery from end-stage failure has been reported following both optimal medical therapy 3 and left ventricular assist device (LVAD) support, 4,5 although the determinants of successful recovery are unknown.It has been proposed that recovery from genetic cardiomyopathy may not be expected because the underlying cause is irre-versible, whereas recovery may be more likely when DCM is caused by reversible, nongenetic factors (eg, myocarditis). 6 To address this directly, we sequenced TTN in patients with end-stage DCM who either recovered or did not recover following LVAD support.
No takes yet. Share an insight, caveat, or question.
Felkin et al. (2016) conducted an observational in End-stage dilated cardiomyopathy (DCM). TTN-truncating variants (TTNtvs) vs. Absence of TTNtvs was evaluated on Recovery of cardiac function following LVAD support. The abstract describes a study sequencing TTN in patients with end-stage dilated cardiomyopathy following LVAD support, but reports no quantitative results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: